Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-mediated thrombocytopenia.

M C Berndt1, P A Castaldi

  • 1Department of Medicine, University of Sydney, Westmead Hospital, NSW, Australia.

Blood Reviews
|June 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary haemostasis: newer insights.

Haemophilia : the official journal of the World Federation of Hemophilia·2014
Same author

The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus formation.

Redox biology·2014
Same author

Specific inhibition of ectodomain shedding of glycoprotein Ibα by targeting its juxtamembrane shedding cleavage site.

Journal of thrombosis and haemostasis : JTH·2013
Same author

ITAM receptor-mediated generation of reactive oxygen species in human platelets occurs via Syk-dependent and Syk-independent pathways.

Journal of thrombosis and haemostasis : JTH·2012
Same author

The amino Acid sequence glutamine-628 to valine-646 within the A1 repeat domain mediates binding of von Willebrand factor to bovine brain sulfatides and equine tendon collagen.

Platelets·2010
Same author

Inhibition of Binding of von Willebrand Factor to the Platelet Glycoprotein Ib-IX Complex, Heparin and Sulfatides by Polyanionic Compounds. The Mechanism of Modulation of the Adhesive Function of von Willebrand Factor.

Platelets·2010

Drug-dependent antibodies cause thrombocytopenia, particularly with quinine/quinidine and heparin. Quinine/quinidine antibodies bind to platelet glycoproteins, while heparin antibody mechanisms remain unclear, necessitating prompt recognition to prevent complications.

Area of Science:

  • Immunology
  • Hematology
  • Pharmacology

Background:

  • Drug-dependent antibodies are a significant cause of thrombocytopenia.
  • Quinine/quinidine and heparin are common culprits, with distinct antibody mechanisms.
  • Understanding these mechanisms is crucial for clinical management.

Purpose of the Study:

  • To review the mechanisms of drug-dependent antibody formation in thrombocytopenia.
  • To compare the known mechanisms of quinine/quinidine-induced antibodies with the less understood heparin-induced antibodies.
  • To highlight the clinical importance of recognizing these conditions.

Main Methods:

  • Review of existing evidence on drug-dependent antibody-mediated thrombocytopenia.
  • Analysis of proposed antibody binding sites and mechanisms for quinine/quinidine and heparin.

Related Experiment Videos

  • Discussion of clinical implications and diagnostic considerations.

    • Main Results:

    • Quinine/quinidine antibodies likely bind loosely to platelet glycoproteins Ib/IX complex, independent of Fc receptors.
    • Heparin-induced thrombocytopenia can manifest as simple thrombocytopenia or a more severe thrombotic condition.
    • The precise antigenic targets and mechanisms for heparin antibodies are not yet fully elucidated.

    Conclusions:

    • Recognition of drug-dependent thrombocytopenia, especially heparin-induced, is vital.
    • Prompt diagnosis and management can prevent severe bleeding or thrombotic events.
    • Further research is needed to clarify the mechanisms of heparin-induced thrombocytopenia.